Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis

Michael B. Donald, Kevin X. Rodriguez, Hannah Shay, Puay Wah Phuan, A. S. Verkman, Mark J. Kurth

Research output: Contribution to journal › Article

10 Citations (Scopus)

Abstract

Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5′- bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96).

Original languageEnglish (US)
Pages (from-to)5247-5253
Number of pages7
JournalBioorganic and Medicinal Chemistry
Volume20
Issue number17
DOIs
StatePublished - Sep 1 2012

Fingerprint

Alkynes
Azides
Cycloaddition
Cystic Fibrosis
Copper
Benchmarking
Cycloaddition Reaction

Keywords

  • CF corrector
  • CuAAC
  • Cystic fibrosis
  • Triazolobithiazole

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology
  • Clinical Biochemistry
  • Biochemistry

Cite this

Donald, M. B., Rodriguez, K. X., Shay, H., Phuan, P. W., Verkman, A. S., & Kurth, M. J. (2012). Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis. Bioorganic and Medicinal Chemistry, 20(17), 5247-5253. https://doi.org/10.1016/j.bmc.2012.06.046

Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis. / Donald, Michael B.; Rodriguez, Kevin X.; Shay, Hannah; Phuan, Puay Wah; Verkman, A. S.; Kurth, Mark J.

In: Bioorganic and Medicinal Chemistry, Vol. 20, No. 17, 01.09.2012, p. 5247-5253.

Research output: Contribution to journal › Article

Donald, MB, Rodriguez, KX, Shay, H, Phuan, PW, Verkman, AS & Kurth, MJ 2012, 'Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis', Bioorganic and Medicinal Chemistry, vol. 20, no. 17, pp. 5247-5253. https://doi.org/10.1016/j.bmc.2012.06.046
Donald MB, Rodriguez KX, Shay H, Phuan PW, Verkman AS, Kurth MJ. Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis. Bioorganic and Medicinal Chemistry. 2012 Sep 1;20(17):5247-5253. https://doi.org/10.1016/j.bmc.2012.06.046
Donald, Michael B. ; Rodriguez, Kevin X. ; Shay, Hannah ; Phuan, Puay Wah ; Verkman, A. S. ; Kurth, Mark J. / Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis. In: Bioorganic and Medicinal Chemistry. 2012 ; Vol. 20, No. 17. pp. 5247-5253.
@article{2d2fef0e603b4e41940758d999b44735,
title = "Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis",
abstract = "Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5′- bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96).",
keywords = "CF corrector, CuAAC, Cystic fibrosis, Triazolobithiazole",
author = "Donald, {Michael B.} and Rodriguez, {Kevin X.} and Hannah Shay and Phuan, {Puay Wah} and Verkman, {A. S.} and Kurth, {Mark J.}",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.bmc.2012.06.046",
language = "English (US)",
volume = "20",
pages = "5247--5253",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "17",

}

TY - JOUR

T1 - Click-based synthesis of triazolobithiazole Δf508-CFTR correctors for cystic fibrosis

AU - Donald, Michael B.

AU - Rodriguez, Kevin X.

AU - Shay, Hannah

AU - Phuan, Puay Wah

AU - Verkman, A. S.

AU - Kurth, Mark J.

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5′- bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96).

AB - Copper catalyzed azide-alkyne cycloaddition (CuAAC) chemistry is reported for the construction of previously unknown 5-(1H-1,2,3-triazol-1-yl)-4,5′- bithiazoles from 2-bromo-1-(thiazol-5-yl)ethanones. These novel triazolobithiazoles are shown to have cystic fibrosis (CF) corrector activity and, compared to the benchmark bithiazole CF corrector corr-4a, improved log P values (4.5 vs 5.96).

KW - CF corrector

KW - CuAAC

KW - Cystic fibrosis

KW - Triazolobithiazole

UR - http://www.scopus.com/inward/record.url?scp=84864984030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864984030&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2012.06.046

DO - 10.1016/j.bmc.2012.06.046

M3 - Article

VL - 20

SP - 5247

EP - 5253

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 17

ER -

Access to Document